Identification of fenoldopam as a novel LSD1 inhibitor to abrogate the proliferation of renal cell carcinoma using drug repurposing strategy
出版年份 2020 全文链接
标题
Identification of fenoldopam as a novel LSD1 inhibitor to abrogate the proliferation of renal cell carcinoma using drug repurposing strategy
作者
关键词
LSD1, Fenoldopam, Renal cell carcinoma, Cancer treatment
出版物
BIOORGANIC CHEMISTRY
Volume -, Issue -, Pages 104561
出版商
Elsevier BV
发表日期
2020-12-17
DOI
10.1016/j.bioorg.2020.104561
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Natural protoberberine alkaloids, identified as potent selective LSD1 inhibitors, induce AML cell differentiation
- (2020) Zhong-Rui Li et al. BIOORGANIC CHEMISTRY
- Expression profile of H3K4 demethylases with their clinical and pathological correlation in patients with clear cell renal cell carcinoma
- (2020) Aman Kumar et al. GENE
- New tranylcypromine derivatives containing sulfonamide motif as potent LSD1 inhibitors to target acute myeloid leukemia: Design, synthesis and biological evaluation
- (2020) Liyun Liang et al. BIOORGANIC CHEMISTRY
- Capsaicin: A “hot” KDM1A/LSD1 inhibitor from peppers
- (2020) Gang Jia et al. BIOORGANIC CHEMISTRY
- Synthesis and biological evaluation of some novel thiobenzimidazole derivatives as anti-renal cancer agents through inhibition of c-MET kinase
- (2019) Hany S. Ibrahim et al. BIOORGANIC CHEMISTRY
- Discovery and synthesis of novel indole derivatives-containing 3-methylenedihydrofuran-2(3H)-one as irreversible LSD1 inhibitors
- (2019) Hong-Min Liu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Effects of fenoldopam on kidney function parameters and its therapeutic efficacy in the management of acute kidney injury in dogs with heatstroke
- (2018) Gilad Segev et al. JOURNAL OF VETERINARY INTERNAL MEDICINE
- Drug repurposing: progress, challenges and recommendations
- (2018) Sudeep Pushpakom et al. NATURE REVIEWS DRUG DISCOVERY
- LSD1 inhibition suppresses the growth of clear cell renal cell carcinoma via upregulating P21 signaling
- (2018) Liangsong Zhu et al. Acta Pharmaceutica Sinica B
- Identification of osimertinib (AZD9291) as a lysine specific demethylase 1 inhibitor
- (2018) Zhong-Rui Li et al. BIOORGANIC CHEMISTRY
- LincRNAFEZF1-AS1 represses p21 expression to promote gastric cancer proliferation through LSD1-Mediated H3K4me2 demethylation
- (2017) Yan-wen Liu et al. Molecular Cancer
- Baicalin, a natural LSD1 inhibitor
- (2016) Yi-Chao Zheng et al. BIOORGANIC CHEMISTRY
- Impact on clinical practice of the implementation of guidelines for the toxicity management of targeted therapies in kidney cancer. The protect-2 study
- (2016) Nuria Lainez et al. BMC CANCER
- Androgen and AR contribute to breast cancer development and metastasis: an insight of mechanisms
- (2016) J Feng et al. ONCOGENE
- A Systematic Review of Histone Lysine-Specific Demethylase 1 and Its Inhibitors
- (2015) Yi-Chao Zheng et al. MEDICINAL RESEARCH REVIEWS
- Landmarks in the diagnosis and treatment of renal cell carcinoma
- (2014) Jaimin R. Bhatt et al. Nature Reviews Urology
- Triazole–Dithiocarbamate Based Selective Lysine Specific Demethylase 1 (LSD1) Inactivators Inhibit Gastric Cancer Cell Growth, Invasion, and Migration
- (2013) Yi-Chao Zheng et al. JOURNAL OF MEDICINAL CHEMISTRY
- Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
- (2013) D. M. Molina et al. SCIENCE
- Epidemiology and risk factors for kidney cancer
- (2010) Wong-Ho Chow et al. Nature Reviews Urology
- Renal cell carcinoma
- (2009) Brian I Rini et al. LANCET
- Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): A literature review
- (2008) Kiran Gupta et al. CANCER TREATMENT REVIEWS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More